Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 79, Iss. 5, 2015-05 ,pp. : 838-846

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is there Evidence to Support the Use of Direct Factor Xa Inhibitors in Coronary Artery Disease?

By  

Reviews on Recent Clinical Trials, Vol. 6, Iss. 2, 2011-05 ,pp. : 147-157

Bentham Science Publishers

Access to resources Recommend Favorite

Oral, direct Factor Xa inhibition with BAY 59‐7939 for the prevention of venous thromboembolism after total hip replacement

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 121-128

John Wiley & Sons Inc

Access to resources Recommend Favorite

Thrombolysis by chemically modified coagulation factor Xa

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 14, Iss. 9, 2016-09 ,pp. : 1844-1854

John Wiley & Sons Inc

Access to resources Recommend Favorite

FES for Bladder: Direct or Indirect Means?

By  

PACING AND CLINICAL ELECTROPHYSIOLOGY, Vol. 10, Iss. 1, 1987-01 ,pp. : 240-245

John Wiley & Sons Inc

Access to resources Recommend Favorite